Our Public Curriculum

Our Public Curriculum

Our Public Curriculum

Learn how pharmaceutical markets, evidence, and regulation affect medicine pricing and access. These six modules introduce key concepts and further reading.

Module 1: Collusion and competition

Module 1: Collusion and competition

Module 1: Collusion and competition

Understand how coordination between competitors can affect prices and market entry, and how authorities distinguish evidence of collusion from ordinary market behavior.

Module 2: Drug pricing and affordability

Module 2: Drug pricing and affordability

Module 2: Drug pricing and affordability

Learn to distinguish list prices, net prices, reimbursement, and patient costs when assessing affordability.

Module 3: Evergreening and market entry

Module 3: Evergreening and market entry

Module 3: Evergreening and market entry

Examine how product changes, patents, and exclusivities interact with generic or biosimilar competition.

Module 4: Kickbacks and prescribing incentives

Module 4: Kickbacks and prescribing incentives

Module 4: Kickbacks and prescribing incentives

Explore how financial arrangements can influence prescribing and reimbursement, and what documented enforcement cases establish.

Module 5: Integrity in clinical evidence

Module 5: Integrity in clinical evidence

Module 5: Integrity in clinical evidence

Learn why trial design, complete reporting, data handling, and independent review matter when judging medical claims.

Module 6: Patents and pharmaceutical innovation

Module 6: Patents and pharmaceutical innovation

Module 6: Patents and pharmaceutical innovation

Understand what patents protect, how they differ from regulatory exclusivity, and how patent disputes can affect market entry.